viimane versioon :
22/08/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
N-acetylcysteine
keemiline struktuur
Viited : N-acetylcysteine
tüüp
avaldamine
549
ajaleht
Owsley HD, Rusho WJ.
Compatibility of common respiratory therapy drug combinations.
Int J Pharm Compound 1997 ; 1: 121-122.
2648
ajaleht
Rieutord A, Arnaud P, Dauphin JF, Brion F.
Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone
Int J Pharm 1999 ; 190, 1: 103-107.
2787
ajaleht
Lee TY, Chen CM, Lee CN, Chaing YC.
Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
2803
ajaleht
Bonasia PJ, McVicar WK, Williams B, Ong S.
Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.
Respiratory Care 2008 ; 683, 12: 1716-1722.
3019
ajaleht
Bonasia P, Cook C, Cheng Y et al.
Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
Curr Med Res Opin 2007 ; 23: 2477-2483.
3498
ajaleht
Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.
Mentions Légales